Rhenium Re 188 P2045 in Patients With Lung Cancer Who Have Received or Refused to Receive Prior Chemotherapy
Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Small Cell
About this trial
This is an interventional treatment trial for Lung Neoplasms focused on measuring Advanced or recurrent stage IIIb or IV non small cell lung cancer, Disseminated or recurrent small cell lung cancer
Eligibility Criteria
Inclusion Criteria: Has histologically or cytologically documented Non-Small-Cell Lung Cancer (NSCLC) or Small-Cell Lung Cancer (SCLC) and has advanced or recurrent IIIb or IV NSCLC (adenocarcinoma, squamous cell carcinoma, large cell, mixed or not otherwise specified) or disseminated or recurrent SCLC or any lung cancer which has local recurrence. Has documentation of progressive disease following prior chemotherapy or who refused to receive standard chemotherapy. Has measurable tumor (at least 1 cm unidimensionally) in a previously non-irradiated area or, if in previously irradiated area, a substantial increase in size of tumor, based on CT scan within 8 weeks prior to enrollment; tumor in previously irradiated area only if it has increased by 50% or more from previous minimal diameter AND it is more than 8 weeks from the radiation.
Sites / Locations
- Recruiting
- Recruiting
Arms of the Study
Arm 1
Experimental
Arm 1